TABLE 2 p53, bcl-2, bax, ER, and PR Expression According to Histologic Type in Endometrial Adenocarcinoma

From: Immunohistochemical Profile of Endometrial Adenocarcinoma: A Study of 61 Cases and Review of the Literature

Histologic Type No. Cases p53+ No. (%) bcl-2+ No. (%) bax+ No. (%) ER+ No. (%) PR+ No. (%)
UEA 40 14 (35) 26 (65) 19 (47.5) 28 (70) 29 (72.5)
UPSA 21 16 (76.2) 14 (66.5) 9 (43) 5 (23.8) 4 (19)
   p =.003 p =.80 p =.56 p =.005 p =.0005
  1. ER, estrogen receptor; PR, progesterone receptor; UEA, uterine edometrioid adenocarcinoma; UPSA, uterine papillary serous adenocarcinoma.